MIC
GSK icon

Means Investment Company’s GSK GSK Stock Holding History

Means Investment Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,873
Closed -$265K – 191
2022
Q2 		$265K Sell
4,873
-193
-4% -$10.7K 0.06% 162
2022
Q1 		$276K Buy
5,066
+362
+8% +$19.7K 0.05% 163
2021
Q4 		$259K Buy
4,704
+318
+7% +$16.5K 0.05% 170
2021
Q3 		$210K Buy
4,386
+9
+0.2% +$452 0.04% 176
2021
Q2 		$218K Sell
4,377
-232
-5% -$11.1K 0.04% 176
2021
Q1 		$206K Sell
4,609
-61
-1% -$2.77K 0.05% 170
2020
Q4 		$206K Buy
4,670
+11
+0.2% +$505 0.05% 173
2020
Q3 		$215K Buy
4,659
+10
+0.2% +$501 0.06% 138
2020
Q2 		$240K Buy
4,649
+5
+0.1% +$257 0.08% 126
2020
Q1 		$243K Sell
4,644
-136
-3% -$7.25K 0.09% 114
2019
Q4 		$286K Buy
4,780
+10
+0.2% +$556 0.1% 119
2019
Q3 		$269K Sell
4,770
-26
-0.5% -$1.34K 0.1% 121
2019
Q2 		$244K Buy
4,796
+498
+12% +$25K 0.1% 123
2019
Q1 		$225K Buy
4,298
+9
+0.2% +$450 0.1% 126
2018
Q4 		$205K Buy
+4,289
New +$211K 0.11% 121

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Means Investment Company's GSK Position: Q3 2022 in Review

Means Investment Company sold out of GSK (GSK) in Q3 2022, closing a stake of 4,873 shares — an estimated $265K sold.

Means Investment Company first reported a position in GSK in Q4 2018 and held it in 15 quarters. The position peaked at $286K in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Means Investment Company reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Means Investment Company sold 4,873 GSK shares in Q3 2022, an estimated $265K.
  • Means Investment Company first reported a position in GSK in Q4 2018 and held it in 15 quarters.
  • Means Investment Company's GSK position peaked at $286K in Q4 2019.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Means Investment Company's 13F filing for Q3 2022, filed 17 Oct 2022.